Spermoprotective properties of Prostatex in patients with chronic abacterial prostatitis

• Published in: Urologii͡a︡ (Moscow, Russia : 1999) no. 1; p. 54
• Main Authors: Neymark, A I, Davydov, A V, Neymark, B A, Nozdrachev, N A, Melnik, M A, Kablova, I V, Borisenko, D V, Tupyakova, S G, Kovaleva, Yu S
• Format: Journal Article
• Language: English; Russian
• Published: Russia (Federation) 01.03.2023
• Subjects: spermatogenesis; chronic prostatitis; Prostatex; spermoprotective therapy
• ISSN: 1728-2985
• DOI: 10.18565/urology.2023.1.54-59

To study the effect of Prostatex therapy on spermatogenesis in patients with infertility that developed due to chronic abacterial prostatitis. A total of 60 men with infertility in marriage and chronic abacterial prostatitis were included in the study. All patients received therapy with Prostatex rectal suppositories 10 mg 1 time per day. The duration of treatment was 30 days. After taking the drug, patients were observed for 50 days. The study was carried out for 80 days and included 3 visits at 1, 30 and 80 days. The study showed that the use of Prostatex rectal suppositories 10 mg had a positive effect on the main indicators of spermatogenesis, as well as on the subjective and objective symptoms of chronic abacterial prostatitis. Based on these results, we recommend Prostatex rectal suppositories to patients with chronic abacterial prostatitis, accompanied by impaired spermatogenesis, according to the scheme: 1 suppository 10 mg 1 time per day for 30 days.